Replies to post #457932 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

"... The most common adverse events with KarXT versus placebo were constipation (27 [21%] vs 13 [10%]), dyspepsia (24 [19%] vs 10 [8%]), headache (17 [14%] vs 15 [12%]), nausea (24 [19%] vs seven [6%]), vomiting (18 [14%] vs one [1%]), hypertension (12 [10%] vs one [1%]), dizziness (11 [9%] vs four [3%]), gastro-oesophageal reflux disease (eight [6%] vs zero [0%]), and diarrhoea (seven [6%] vs four [3%]). Treatment-emergent adverse event rates of extrapyramidal motor symptoms (KarXT, zero [0%] vs placebo, zero [0%]), akathisia (one [1%] vs one [1%]), weight gain (zero [0%] vs one [1%]), and somnolence (six [5%] vs five [4%]) were similar between the KarXT and placebo groups, as were adverse event-related discontinuation rates (nine [7%] vs seven [6%])...."

Karuna and now BMS's KarXT.

Anavex 3-71 no reported side effects and very well tolerated.

GOD bless,

[mauismart]

And nobody is interested In reading your posts ..only your handlers.

[mauismart]

We have a bunch of losers attacking a company that could help your grand parents. Maybe it is one person with 6 aliases in a cubicle in miami.